Vinblastine, ifosfamide, gallium nitrate, and filgrastim in platinum- and paclitaxel-resistant ovarian cancer. A phase II study

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 3, 1998, Pages 287-290

  Dreicer, Robert ^a,b   Lallas, Thomas A ^a   Joyce, Jacqueline K ^a   Anderson, Barrie ^a   Sorosky, Joel I ^a   Buller, Richard E ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE   (United States)

Author keywords

Gallium nitrate; Ifosfamide; Ovarian cancer; Vinblastine

Indexed keywords

CA 125 ANTIGEN; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CARBOPLATIN; CISPLATIN; CREATININE; GALLIUM NITRATE; IFOSFAMIDE; MESNA; PACLITAXEL; PLATINUM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESISTANCE; FEMALE; HUMAN; HYPOCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; OVARY CANCER; PHASE 2 CLINICAL TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FILGRASTIM; GALLIUM; HUMANS; IFOSFAMIDE; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; VINBLASTINE;

EID: 0031814410     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199806000-00017     Document Type: Article

References (13)

1. Thigpen JT, Vance RB, Khansur T. Second-line chemotherapy for recurrent carcinoma of the ovary. Cancer 1993;71:1559-64.
2. Qazi F, McGuire WP. The treatment of epithelial ovarian cancer. CA Cancer J Clin 1995;45:88-101.
3. Seidman AD, Scher HI, Heinemann MH, et al. Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors. Cancer 1991;68:2561-5.
4. Witte RS, Elson P, Bono B, et al. Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma. J Clin Oncol 1997; 14:589-93.
5. Einhorn LH, Roth BJ, Ansari R, et al. Phase II trial of vinblastine, ifosfamide and gallium combination chemotherapy in metastatic urothelial carcinoma. J Clin Oncol 1994;12:2271-6.
6. Dreicer R, Propert KH, Roth BJ, et al. Vinblastine, ifosfamide and gallium nitrate (VIG), an active new regimen in advanced carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. Cancer 1997;79:110-4.
7. Markman M, Hakes T, Reichman B, et al. Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer. Activity in platinum-resistant disease. J Clin Oncol 1992;10:243-8.
8. Malfetano JH, Blessing JA, Adelson MD. A phase II trial of gallium nitrate in previously treated ovarian carcinoma: a Gynecologic Oncology Group Study. Am J Clin Oncol 1991;14:349-51.
9. McGuire WP, Rowinsky EK, Rosensheim NB, et al. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian neoplasms. Ann Intern Med 1989;111:273-9.
10. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
11. Bajetta E, Di Leo A, Biganzoli L, et al. Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease. J Clin Oncol 1996; 14:2546-51.
12. Creemers GJ, Bolis G, Gore M, et al. Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II trial. J Clin Oncol 1996;14:3056-61.
13. Gordon A, Bookman M, Malmstrom H, et al. Efficacy of topotecan in advanced epithelial ovarian cancer after failure of platinum and paclitaxel: International Topotecan Study Group trial [Abstract]. Proceedings of the American Society of Clinical Oncology 1996;15:232.